Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 5
2006 3
2007 7
2008 3
2009 12
2010 8
2011 3
2012 5
2013 10
2014 10
2015 8
2016 11
2017 9
2018 13
2019 13
2020 15
2021 15
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Discharge protocol in acute pancreatitis: an international survey and cohort analysis.
Nagy R, Ocskay K, Sipos Z, Szentesi A, Vincze Á, Czakó L, Izbéki F, Shirinskaya NV, Poluektov VL, Zolotov AN, Zhu Y, Xia L, He W, Sutton R, Szatmary P, Mukherjee R, Burridge IS, Wauchope E, Francisco E, Aparicio D, Pinto B, Gomes A, Nunes V, Tantau VM, Sagau ED, Tantau AI, Suceveanu AI, Tocia C, Dumitru A, Pando E, Alberti P, Cirera A, Molero X, Lee HS, Jung MK, Kim EJ, Lee S, Rebollo MLR, Nistal RB, Santervas SI, Lesko D, Soltes M, Radonak J, Zatorski H, Małecka-Panas E, Fabisiak A, Yaroslav MS, Mykhailo VM, Olekcandr AT, Barauskas G, Simanaitis V, Ignatavicius P, Jinga M, Balaban VD, Patoni C, Gong L, Song K, Li Y, Gonçalves TC, Freitas M, Macedo V, Vornhuelz M, Klauss S, Beyer G, Koksal AS, Tozlu M, Eminler AT, Monclús NT, Comas EP, Oballe JAR, Nawacki Ł, Głuszek S, Rama-Fernández A, Galego M, de la Iglesia D, Aykut UE, Duman DG, Aslan R, Gherbon A, Deng L, Huang W, Xia Q, Poropat G, Radovan A, Vranić L, Ricci C, Ingaldi C, Casadei R, Negoi I, Ciubotaru C, Iordache FM, Constantinescu G, Sandru V, Altintas E, Balci HR, Constantino J, Aveiro D, Pereira J, Gunay S, Misirlioglu Sucan S, Dronov O, Kovalska I, Bush N, Rana SS, Chooklin S, Chuklin S, Saizu IA, Gheorghe C, Göltl… See abstract for full author list ➔ Nagy R, et al. Among authors: malecka panas e. Sci Rep. 2023 Dec 13;13(1):22109. doi: 10.1038/s41598-023-48480-z. Sci Rep. 2023. PMID: 38092809 Free PMC article.
Leukocytapheresis in patients with inflammatory bowel diseases.
Woźniak M, Kurnatowska I, Małecka-Panas E, Talar-Wojnarowska R. Woźniak M, et al. Among authors: malecka panas e. Prz Gastroenterol. 2021;6(2):99-105. doi: 10.5114/pg.2021.106658. Epub 2021 Jun 4. Prz Gastroenterol. 2021. PMID: 34276835 Free PMC article. Review.
Lifestyle Modifications and Colorectal Cancer.
Durko L, Malecka-Panas E. Durko L, et al. Among authors: malecka panas e. Curr Colorectal Cancer Rep. 2014;10(1):45-54. doi: 10.1007/s11888-013-0203-4. Curr Colorectal Cancer Rep. 2014. PMID: 24659930 Free PMC article. Review.
Barrett's esophagus in 2016: From pathophysiology to treatment.
Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Martinucci I, et al. Among authors: malecka panas e. World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):190-206. doi: 10.4292/wjgpt.v7.i2.190. World J Gastrointest Pharmacol Ther. 2016. PMID: 27158534 Free PMC article. Review.
Biosimilar biological drugs in the treatment of inflammatory bowel diseases.
Kaniewska M, Eder P, Gąsiorowska A, Gonciarz M, Kierkuś J, Małecka-Panas E, Rydzewska G. Kaniewska M, et al. Among authors: malecka panas e. Prz Gastroenterol. 2019;14(4):223-227. doi: 10.5114/pg.2019.90093. Epub 2019 Dec 20. Prz Gastroenterol. 2019. PMID: 31988667 Free PMC article. Review.
141 results